RADIOMICS.BIO: Keyword Density Checker

Total words: 2437 | 2-word phrases: 656 | 3-word phrases: 697 | 4-word phrases: 709

PAGE INFO

Title	Try to keep the title under 60 characters (51 characters) Radiomics Insight-based decision making I Radiomics
Description	Try to keep the meta description between 50 - 160 characters (299 characters) Radiomics is a next generation imaging spin-out company from Maastricht University, founded in 2016 and based in Liège, Belgium. Radiomics focuses on AI powered healthcare, with a unique expertise in Radiomics, Deep Learning & Federated Learning applied to oncology and other therapeutic areas.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (42 characters) Radiomics.bioInsight-based decision making

ONE WORD PHRASES 375 Words

#	Keyword	Frequency	Density
1	and	30	8.00%
2	to	28	7.47%
3	the	21	5.60%
4	of	15	4.00%
5	in	14	3.73%
6	a	12	3.20%
7	radiomics	11	2.93%
8	your	9	2.40%
9	our	8	2.13%
10	you	7	1.87%

TWO WORD PHRASES 656 Words

#	Keyword	Frequency	Density
1	and the	4	0.61%
2	healthcare professionals	4	0.61%
3	clinical trial	4	0.61%
4	read more	4	0.61%
5	therapeutic areas	4	0.61%
6	diseases and	4	0.61%
7	scientific researchers	3	0.46%
8	discover our	3	0.46%
9	partners in	3	0.46%
10	and therapeutic	3	0.46%
11	with a	3	0.46%
12	oncology and	3	0.46%
13	of cookies	3	0.46%
14	highly effective	2	0.30%
15	types of	2	0.30%
16	clients and	2	0.30%
17	and partners	2	0.30%
18	13485 certification	2	0.30%
19	iso 13485	2	0.30%
20	we are	2	0.30%

THREE WORD PHRASES 697 Words

#	Keyword	Frequency	Density
1	diseases and therapeutic	3	0.43%
2	and therapeutic areas	3	0.43%
3	device healthcare professionals	2	0.29%
4	medical device healthcare	2	0.29%
5	general hospital aims	2	0.29%
6	hospital aims to	2	0.29%
7	aims to accelerate	2	0.29%
8	clinical trial support	2	0.29%
9	imaging lab clinical	2	0.29%
10	lab clinical trial	2	0.29%
11	central imaging lab	2	0.29%
12	pharma central imaging	2	0.29%
13	industry pharma central	2	0.29%
14	new and highly	2	0.29%
15	oncology respiratory other	2	0.29%
16	areas oncology respiratory	2	0.29%
17	institutional news general	2	0.29%
18	healthcare professionals disease	2	0.29%
19	professionals disease detection	2	0.29%
20	project at the	2	0.29%
21	treatment read more	2	0.29%
22	pilot project at	2	0.29%
23	toolbox collaborative researchgrants	2	0.29%
24	radiomix toolbox collaborative	2	0.29%
25	training radiomix toolbox	2	0.29%
26	and training radiomix	2	0.29%
27	some types of	2	0.29%
28	the jewish general	2	0.29%
29	types of cookies	2	0.29%
30	scientific researchers academia	2	0.29%

FOUR WORD PHRASES 709 Words

#	Keyword	Frequency	Density
1	diseases and therapeutic areas	3	0.42%
2	some types of cookies	2	0.28%
3	central imaging lab clinical	2	0.28%
4	great place to work	2	0.28%
5	place to work job	2	0.28%
6	to work job openings	2	0.28%
7	and therapeutic areas oncology	2	0.28%
8	therapeutic areas oncology respiratory	2	0.28%
9	areas oncology respiratory other	2	0.28%
10	industry pharma central imaging	2	0.28%
11	pharma central imaging lab	2	0.28%
12	imaging lab clinical trial	2	0.28%
13	careers a great place	2	0.28%
14	lab clinical trial support	2	0.28%
15	medical device healthcare professionals	2	0.28%
16	device healthcare professionals disease	2	0.28%
17	healthcare professionals disease detection	2	0.28%
18	radiomix toolbox collaborative researchgrants	2	0.28%
19	followup outcome prediction scientific	2	0.28%
20	outcome prediction scientific researchers	2	0.28%
21	prediction scientific researchers academia	2	0.28%
22	training radiomix toolbox collaborative	2	0.28%
23	a great place to	2	0.28%
24	and training radiomix toolbox	2	0.28%
25	and highly effective treatments	2	0.28%
26	project at the jewish	2	0.28%
27	at the jewish general	2	0.28%
28	the jewish general hospital	2	0.28%
29	jewish general hospital aims	2	0.28%
30	institutional news general news	2	0.28%
31	the company the people	2	0.28%
32	treatments for cancer patients	2	0.28%
33	effective treatments for cancer	2	0.28%
34	general hospital aims to	2	0.28%
35	hospital aims to accelerate	2	0.28%
36	highly effective treatments for	2	0.28%
37	pilot project at the	2	0.28%
38	new and highly effective	2	0.28%
39	to new and highly	2	0.28%
40	in immunotherapy up to	1	0.14%